Daniela Salvemini

Saint Louis University

NIH Rank #2314
  • R01 Holder
  • Translational
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.2M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#2,314
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.2M across 5 grants · National rank #2314.

Top grants by award amount

Daniela Salvemini's NIH grant portfolio, ranked by award amount.

  • 1R61NS138976-01R61
    Development of selective GPR34 antagonists for the treatment of neuropathic pain
    $1.5M
    award amount
  • 1R01NS138127-01R01
    Molecular basis for functional S1PR1 antagonists in the treatment of comorbid migraine and temporomandibular disorders
    $620.3K
    award amount
  • 5R01CA261979-03R01
    Fingolimod and Ozanimod for the treatment and prevention of chemobrain
    $458.8K
    award amount
  • 5R01NS120930-03R01
    Molecular basis for adenosine A3 receptor agonists in the treatment of migraine
    $458.7K
    award amount
  • 5R21CA277436-02R21
    GPR160 antibody development for cancer treatment
    $168.2K
    award amount

Affiliations

Institutions that have administered grants for Daniela Salvemini.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Saint Louis University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2314
  6. 2024
    Entered Top 25% Nationally
    Ranked #2314
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions